brca4 | 59565

Genetics Ashkenazi panel (BRCA1, BRCA2)

Keywords

Ashkenazim, BRCA1, BRCA1 c.69_69del, BRCA1 c.5266dup, BRCA2, BRCA2 c.5946del

Material
Blood EDTA
EDTA tube, purple (6)
Note

Mutations in the genes BRCA1 (c.69_69del and c.5266dup) and BRCA2 (c.4946del), which are abundant in Ashkenazi Jews, are tested using next-generation sequencing. | Declaration of consent for genetic examination in accordance with GUMG required (see OF Human genetics or www.viollier.ch/en/SGMG_consent) | There is a possibility of excess information occurring with this analysis. This will be communicated, unless it is noted otherwise when placing the order.

Min. quantity 4 mL
Stability 1 week / 2-8°C
Duration 3 weeks
Frequency 1 x per month
Method Next Generation Sequencing
Price CHF 725.40
Tariff 725.40 TP

Team of consultants

PhD Christoph Noppen FAMH Specialist in laboratory medicine, medical genetics
FAMH Specialist in laboratory medicine, medical genetics T +41 61 486 14 79
DSc Henriette Kurth FAMH Specialist in laboratory medicine, medical genetics
FAMH Specialist in laboratory medicine, medical genetics T +41 61 486 14 78
Dr. sc. nat. Andrea Salzmann Candidate FAMH Specialist in laboratory medicine, main field medical genetics
Candidate FAMH Specialist in laboratory medicine, main field medical genetics T +41 61 486 14 80